Property | Value | Creator | Evidence | PMID | Comment |
Interaction | RegulatedBy Rv0981 | yamir.moreno | IEP | | Microarrays. mRNA levels of regulated element measured and compared between wild-type and trans-element mutation (knockout, over expression etc.) performed by using microarray (or macroarray) experiments.. H. He, R. Hovey et al. MprAB is a stress-responsive two-component system that directly regulates expression of sigma factors SigB and SigE in Mycobacterium tuberculosis. J. Bacteriol. 2006 |
Citation | Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate. authors,R. Zheng,TK. Dam,CF. Brewer,JS. Blanchard Biochemistry 2004 | jevans | | 15170354 | Highly conserved residues His44, His47, Asn69, Gln72 and Lys160 are essential for formationof the pantoyl-adenylate intermediate |
Citation | The design and synthesis of inhibitors of pantothenate synthetase. authors,KL. Tuck,SA. Saldanha,LM. Birch,AG. Smith,C. Abell Org. Biomol. Chem. 2006 | jevans | | 16990935 | Analogues of the pantoyl-adenylate intermediate in which the phosphodiester is replaced by a sulfamoyl group are potent inhibitors. |
Citation | A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase. EL. White, K. Southworth et al. Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening 2007 | jevans | | 17175524 | Inhibited by the vasodilator, nafronyl oxalate, but no whole cell activity in vitro. |
Citation | 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs. authors,S. Velaparthi,M. Brunsteiner,R. Uddin,B. Wan,SG. Franzblau,PA. Petukhov J. Med. Chem. 2008 | jevans | | 18335974 | The tert-butyl and pyrazole portions of 5-tert-Butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives are crucial for pantothenate synthetase inhibition. |
Citation | Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase. authors,AW. Hung,HL. Silvestre,S. Wen,A. Ciulli,TL. Blundell,C. Abell Angew. Chem. Int. Ed. Engl. 2009 | jevans | | 19780086 | 5-methoxyindole competitively inhibits ATP binding. |
Citation | A comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies. authors,YS. Tan,G. Fuentes,C. Verma Proteins 2011 | jevans | | 21425349 | N-terminal domain gate loop motions dominate in Mtb pantothenate synthetase, as opposed to C-terminal domain motions that dominate in E. coli PS |
Citation | A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition. authors,Y. Yang,P. Gao,Y. Liu,X. Ji,M. Gan,Y. Guan,X. Hao,Z. Li,C. Xiao Bioorg. Med. Chem. Lett. 2011 | jevans | | 21641210 | Weakly inhibited by actinomycin D |
Citation | Positional isotope exchange analysis of the pantothenate synthetase reaction. authors,L. Williams,R. Zheng,JS. Blanchard,FM. Raushel Biochemistry 2003 | jevans | | 12718554 | Catalyses the formation of a pantoyl-adenylate intermediate upon the ordered addition of ATP and pantoate. |